
Insmed’s once-daily TPIP prodrug shows sustained lung vasodilation in PAH and PH-ILD, improving walk distance, PALM outcomes, and quality of life.
The American Journal of Managed Care
over 28 years ago
Cost of Migraine Management: A Pharmacoeconomic Overviewover 28 years ago
A New Gatekeeper for Back Painover 28 years ago
Alzheimer's Disease: Clinical Features and Pharmacologic Management





